Pharmaceuticals, Biotechnology and Life Sciences
Castellum, Inc. Announces Closing of Public Offering Castellum, Inc. (NYSE: CTM) (“Castellum”, or the “Company”), a cybersecurity, electronic warfare, and…
TORONTO, Oct. 17, 2022 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold…
Quality of Life –Bronchiectasis (QOL – B (NTM)) Assessments * The percentage of subjects improved/remain unchanged at Day 85. The…
SOUTH SAN FRANCISCO, Calif., Oct. 17, 2022 (GLOBE NEWSWIRE) — DICE Therapeutics, Inc. (Nasdaq: DICE), a biopharmaceutical company leveraging its…
Company On-track to Report Initial Data from Friedreich Ataxia Phase 1 Trial of DT-216 in the Fourth Quarter of 2022CARLSBAD,…
SANTA ANA, Calif., Oct. 17, 2022 (GLOBE NEWSWIRE) — NKGen Biotech, Inc., a biotechnology company harnessing the power of the…
– BridgeBio to host investor call today (October 17, 2022) at 1:30 pm ET to discuss its two most advanced…
Figure 1 Trusting Heart Blood Centers feature modernized facilities offering donors a high-quality experience. Results underscore the initial safety and…
Oculis SA and European Biotech Acquisition Corp announce business combination agreement to create Nasdaq-listed biopharmaceutical company driving breakthrough innovations in…
Phase 1 Study (with 58 healthy volunteers) of STI-1558 was completed in Australia with 300 mg, 600 mg, 1,200 mg…